Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Catalent Appoints Nakaya Matsumaru as General Manager of its New Clinical Supply Facility in Shiga, Japan


Nakaya Matsumaru, General Manager of Catalent Minakuchi

Nakaya Matsumaru, General Manager of Catalent Minakuchi

Nick brings a great deal of experience, and will play an important role in the ongoing expansion of Catalent’s Asia-Pacific network and ensuring that customers’ clinical trials continue to be well-served across the region, and worldwide

Catalent, the leading global provider of advanced delivery technologies, development, manufacturing and clinical supply solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced the appointment of Nakaya “Nick” Matsumaru as General Manager of its new clinical packaging facility in Minakuchi, located in the Shiga prefecture of Japan.

Reporting to Roel de Nobel, Catalent’s Vice President of Operations for Europe and Asia-Pacific, Mr. Matsumaru joins the company from SymBio Pharmaceuticals Ltd, where he held the role of Senior Director Supply Chain & Quality Assurance. Prior to this, he spent four years in vice president, executive officer and head of operations posts with AstraZeneca, and seven years in Japan-based supply chain management with Johnson & Johnson and Janssen. He holds a bachelor’s degree in sociology from Keio University in Tokyo.

“We are pleased to welcome Nick to head our clinical supplies business at our new facility in Shiga, which in partnership with our existing Japanese facility in Kakegawa, will provide flexible clinical supply solutions to customers in Japan and global biotech and pharmaceutical companies,” commented Mr. de Nobel. He added, “Nick brings a great deal of experience, and will play an important role in the ongoing expansion of Catalent’s Asia-Pacific network and ensuring that customers’ clinical trials continue to be well-served across the region, and worldwide.”

Catalent announced it had completed the acquisition of the 60,000-square-foot facility in Shiga from Teva-Takeda Pharmaceuticals in July 2020. The facility is the latest in Catalent’s expanding Asia-Pacific clinical supplies network, and alongside the existing Japanese facility in Kakegawa, the company’s two sites in China and one in Singapore, will offer extensive services including access to primary and secondary packaging capabilities, Catalent’s FastChain® demand-led supply services, a range of temperature options for storage and distribution, as well as clinical returns and destruction services.

About Catalent Clinical Supply Services

Catalent is a global leader in clinical supply services, with comprehensive and flexible solutions for small molecules, biologics, and cell and gene therapies and integrated solutions to accelerate speed to clinic. Catalent offers a full range services including clinical supply management, comprehensive packaging solutions, comparator sourcing, cold chain storage and global distribution and specialized supply chain services including direct-to-patient and demand-led supply. With nine GMP clinical packaging facilities and over 50 strategically located depots on six continents combined with more than 25 years’ experience across thousands of studies in more than 80 countries, Catalent has the comprehensive services, global scale and expertise necessary to reliably supply clinical trials of all sizes and complexity anywhere in the world.

About Catalent

Catalent is the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. With over 85 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable global clinical and commercial product supply. Catalent employs approximately 14,000 people, including around 2,400 scientists and technicians, at more than 45 facilities, and in fiscal year 2020 generated over $3 billion in annual revenue. Catalent is headquartered in Somerset, New Jersey. For more information, visit http://www.catalent.com

More products. Better treatments. Reliably supplied.™

Share article on social media or email:

DuPont Nutrition & Biosciences Launches Enzymes for Sweet Baked Goods in Japan


News Image

“Consumer demand for baked goods with a delicious, sweet taste and long shelf life is growing rapidly across Japan, and we see POWERFresh® Special and POWERSoft® Cake 8010 as an essential to helping the baking industry meet that need,” said Tsukahara Kazuyuki, DuPont Nutrition & Biosciences.

DuPont Nutrition & Biosciences (DuPont) announced today the launch of POWERFresh® Special and POWERSoft® Cake 8010 in Japan. This range of DuPont™ Danisco® enzymes offers improver houses and industrial bakeries an outstanding anti-staling solution that provides a unique texture, premium softness and a longer-lasting freshness to cakes, breads, sweet rolls and buns whilst maintaining their shape.

Improver houses, oils and fats manufacturers and bakeries in Japan are always looking to offer novel eating experiences to customers, while improving productivity and reducing product returns. To help them meet these challenges, DuPont added new enzymes to the range of freshness solutions available in Japan – POWERFresh® Special 8100 GF and 8013, as well as POWERSoft® Cake 8010.

These POWERFresh® and POWERSoft® enzymes were specifically formulated to help create cakes and sweet breads with an ultimate softness and moistness that creates the “melt in your mouth” sensation that consumers want. The enzymes help provide sweet rolls, buns and cakes with a long shelf life and higher resiliency, while providing bakeries a solution that can be applied in a broad variety of recipes with its superior sugar tolerance, without influencing the overall production process.

“Consumer demand for baked goods with a delicious, sweet taste and long shelf life is growing rapidly across Japan, and we see POWERFresh® Special and POWERSoft® Cake 8010 as an essential to helping the baking industry meet that need,” said Tsukahara Kazuyuki, application specialist, DuPont Nutrition & Biosciences. “No other solution on the market offers similar anti-staling capabilities to meet the demand for soft, moist, less crumbling cakes, and sweet rolls and buns while improving productivity, flexibility and shelf life,” he added.

DuPont Nutrition & Biosciences produces enzymes that deliver sustainable innovations across a wide variety of food and beverage products. Learn more about the POWERFresh® and POWERSoft® enzymes and other solutions at https://www.dupontnutritionandbiosciences.com/product-range/food-enzymes/bakery-enzymes.html.

About DuPont™ Danisco®

DuPont™ Danisco® is the brand for a range of ingredients that help provide enhanced bioprotection, an improved nutritional profile, and better taste and texture with greater cost efficiency and lower environmental impact, meeting the needs of manufacturers of food and beverages, dietary supplements and pet food. Through the work of the global network of food scientists and technologists in DuPont, the Danisco® range is supported by a uniquely broad spectrum of know-how across applications and processing. http://www.danisco.com.

About DuPont Nutrition & Biosciences

DuPont Nutrition & Biosciences applies expert science to advance market-driven, healthy and sustainable solutions for the food, beverage, dietary supplement and pharmaceutical industries. We also use cutting-edge biotechnology across a range of markets to advance bio-based solutions to meet the needs of a growing population, while protecting our environment for future generations. We are innovative solvers who help our customers turn challenges into high-value business opportunities. For more information: http://www.dupontnutritionandbiosciences.com.

About DuPont

DuPont (NYSE: DD) is a global innovation leader with technology-based materials, ingredients and solutions that help transform industries and everyday life. Our employees apply diverse science and expertise to help customers advance their best ideas and deliver essential innovations in key markets including electronics, transportation, construction, water, health and wellness, food, and worker safety. More information can be found at http://www.dupont.com. Investors can access information included on the Investor Relations section of the website at investors.dupont.com.

12/10/20

DuPont™, the DuPont Oval Logo, and all trademarks and service marks denoted with ™, SM or ® are owned by affiliates of DuPont de Nemours, Inc. unless otherwise noted.

Share article on social media or email:

Help.org Names the Best Drug and Alcohol Rehab Centers in Raleigh


News Image

Help.org, a trusted online resource for individuals who struggle with addiction and their loved ones, has announced the Best Rehab Facilities in Raleigh, NC for 2021. The informational guide recognizes the top 13 rehab facilities based on cost, treatment options, location, accompanying services and more.

According to recent studies, drug overdose is the leading cause of death among people under age 50. In Raleigh, deaths related to opioid abuse increased significantly from 2011 to 2015. Substance abuse among adolescents is also escalating in Raleigh with 55 percent of high school students reported using alcohol, 38 percent reported using marijuana, 8 percent reported using prescription drugs without a valid prescription, and 2 percent reported using heroin. With the growing need for accessible and high-quality rehab programs, Help.org has developed a unique ranking process to help connect individuals with treatment providers that meet their needs.

The Help.org research team analyzed thousands of facilities across the country and then identified the most cost-effective and highest rated programs in larger cities like Raleigh. Each facility was evaluated based on rehabilitation services, treatment approaches, cost, special programs for unique demographics and ancillary services. The website also provides information about drug use and side effects as well as educational articles. For a detailed listing of the Best Rehab Facilities in Raleigh, NC please visit https://www.help.org/drug-and-alcohol-rehab-centers-in-raleigh-nc/

2021 Best Rehab Facilities in Raleigh, NC (in alphabetical order)

Addictive Behavior Counseling Services

107 Windel Drive, #207 Raleigh, NC 27609

919-274-8001

First Step Services of Raleigh

211 E. Six Forks Road Suite117 1 NC 27609

919-833-8899

Genesis DWI Services

319 Chapanoke Rd, Suite 114-G Raleigh, NC 27603

919-328-9022

Green Hill Recovery

723 West Johnson Street, Suite 100 Raleigh, NC 27603

984-204-1106

Holly Hill Hospital

3019 Falstaff Road Raleigh, NC 27610

919-250-7000

MindPath Care Centers – Bush Street

3610 Bush Street Raleigh, NC 27609

919-876-3130

NCDHHS – Walter B. Jones Center

101 Blair Drive Raleigh, NC 27603

919-855-4800

New Season

3911 New Bern Avenue Raleigh, NC 27610

877-284-7074

SouthLight Healthcare

3125 Poplarwood Court, Suite 203 Raleigh, NC 27604

919-787-6131

The Insight Program

103 Towerview Court Cary, NC 27513

770-751-8383

Triangle Springs

10901 World Trade Boulevard Raleigh, NC 27617

919-746-8900

UNC Health Care Addiction Treatment Center at WakeBrook

107 Sunnybrook Road Raleigh, NC 27610

984-974-4800

Welwyn Outpatient Center

7200 Falls of Neuse Road, #300 Raleigh, NC 27615

984-200-2780

ABOUT HELP.ORG

Help.org is an online resource for individuals who struggle with addiction and their loved ones. The website provides the latest research through scientifically proven methods, community recovery resources as well as information about local financial assistance. Help.org’s team of researchers, activists and writers work together with addiction counselors and other professionals to offer useful and accurate resources to help individuals seeking recovery. To learn more, visit https://www.help.org/.

Share article on social media or email:

Presto Posts Significant Growth by Bringing New Solutions, Expanding Market Base


By launching several new solutions and signing key national agreements, Presto has further consolidated its status as one of the largest providers of restaurant technology. The company has rapidly expanded its customer base due to new solutions like contactless dining and computer vision technology. It currently has over 100 million active monthly users and 300,000 systems shipped across three continents.

Presto’s recent growth has been fueled by the launch of several new technologies for drive-thru performance optimization, contactless ordering / payment, and staff enablement. Its strategic partnerships with important industry leaders such as PayPal, Google, and Fiserv provide valuable access to global markets and help it scale rapidly. With Presto, restaurants across the world not only have the best technology today, but also get a continuous stream of innovation and a variety of complementary technologies to support their future needs.

“Presto has experienced triple-digit growth year-over-year, thanks to our focus on innovation and customer success,” says CEO Raj Suri. “We are proud to bring industry-leading contactless ordering and payment technologies to help the industry cope with current challenges.”

Enterprise-Grade Technology

Originally known for its pay-at-table offering, Presto has quickly expanded to become the restaurant industry’s only end-to-end front-of-house technology platform. In addition to enhancing the guest experience, the Presto platform enables staff efficiency (Server Handheld, Line Busting Tablet, Wearable Watch) and data-driven insights for managers (Analytics & Reporting, Computer Vision, Predictive AI). Presto has also doubled its customer base by helping thousands of restaurants reopen across the world during the pandemic. Guests can enjoy a personalized, on-demand dining experience anywhere with Presto’s new Contactless Order & Pay, Self-Service Kiosk, and Drive-Thru Solutions.

COVID Tech Connect

To further its commitment to the community, Presto has partnered with the COVID Tech Connect initiative. Volunteers from across the country are coming together to supply hospitals and senior care facilities with smart devices so critically ill patients can communicate with loved ones during their last moments. The initiative has received significant national media coverage, raised over $4M, and delivered 6,000 smart devices. Please visit covidtechconnect.com to learn more about this initiative.

For more information on any Presto product or to schedule a demo, please contact mktg@presto.com or visit presto.com.

About Presto

Presto is transforming the restaurant industry by offering innovative, enterprise-grade technologies. Its platform enables operational efficiency and data-driven insights while enhancing guest experience. The highly customizable platform includes powerful solutions for guests (pay-at-table, kiosk, mobile SDK), staff (server handheld, line buster), and managers (computer vision, wearable, A.I. & analytics). Founded in 2008 at the Massachusetts Institute of Technology (MIT) and now based in Silicon Valley, California, Presto is currently used by the majority of the top 20 restaurant chains in the U.S. including Applebee’s, Chili’s Grill & Bar, Denny’s, and Outback Steakhouse.

Share article on social media or email:

Help.org Names the Best Drug and Alcohol Rehab Centers in Reno


News Image

Help.org, a trusted online resource for individuals who struggle with addiction and their loved ones, has announced the Best Rehab Facilities in Reno, NV for 2021. The informational guide recognizes the top 12 rehab facilities based on cost, treatment options, location, accompanying services and more.

According to recent studies, drug overdose is the leading cause of death among people under age 50. In Reno, deaths related to opioid abuse increased significantly from 2011 to 2015. Substance abuse among adolescents is also escalating in Reno with 55 percent of high school students reported using alcohol, 38 percent reported using marijuana, 8 percent reported using prescription drugs without a valid prescription, and 2 percent reported using heroin. With the growing need for accessible and high-quality rehab programs, Help.org has developed a unique ranking process to help connect individuals with treatment providers that meet their needs.

The Help.org research team analyzed thousands of facilities across the country and then identified the most cost-effective and highest rated programs in larger cities like Reno. Each facility was evaluated based on rehabilitation services, treatment approaches, cost, special programs for unique demographics and ancillary services. The website also provides information about drug use and side effects as well as educational articles. For a detailed listing of the Best Rehab Facilities in Reno, NV please visit https://www.help.org/drug-and-alcohol-rehab-centers-in-reno-nv/

2021 Best Rehab Facilities in Reno, NV (in alphabetical order)

Advanced DUI School & Counseling

1000 Bible Way #66 Reno, NV 89502

775-233-5316

Bristlecone Family Resources

704 Mill Street Reno, NV 89502

775-954-1400

Charter Recovery

542 Lander Street Reno, Nevada 89509

775-337-6566

New Dawn Treatment Centers

9408 Double R Boulevard, Suite B Reno, NV 89521

866-969-4300

Reno Behavioral Healthcare Hospital

6940 Sierra Center Parkway Reno, NV 89511

775-393-2200

Renown Behavioral Health

85 Kirman Avenue, Suite 100 Reno, NV 89502

775-982-5318

Step 1, Inc.

1015 N Sierra Street Reno, NV 89503

775-329-9830

STEP2

3700 Safe Harbor Way Reno, NV 89512

775-787-9411

The Empowerment Center

7400 South Virginia Street Reno, Nevada 89511

775-853-5441

The Life Change Center

130 Vine Street Reno, NV 89503

775-900-8522

West Hills Behavioral Hospital

1240 East Ninth Street Reno, NV 89512

800-242-0478

Willow Springs Center

690 Edison Way Reno, NV 89502

800-448-9454

ABOUT HELP.ORG

Help.org is an online resource for individuals who struggle with addiction and their loved ones. The website provides the latest research through scientifically proven methods, community recovery resources as well as information about local financial assistance. Help.org’s team of researchers, activists and writers work together with addiction counselors and other professionals to offer useful and accurate resources to help individuals seeking recovery. To learn more, visit https://www.help.org/.

Share article on social media or email:

Eurasia Group & B3’s GZERO Summit Latin America Focuses on Challenges and Opportunities in a Post-Pandemic World


“A year of unprecedented health and economic challenges throughout Latin America calls for critical discussions about the factors that will lead to recovery and progress.”

A year of unprecedented health and economic challenges throughout Latin America calls for critical discussions about the factors that will lead to recovery and progress. The Covid-led disruption of ordinary life has inspired Eurasia Group, the world’s leading geopolitical risk firm, and B3, the Brazilian stock exchange and Latin America’s leading financial market infrastructure company, to launch the GZERO Summit Latin America. Held virtually on 14 and 15 December, the event will bring together the regions leaders and policymakers in the public and private sectors to examine fast-moving trends and address Latin America’s key challenges. You can read more about the Summit at: https://latam.gzerosummit.com/.

Speakers at the Summit will include Colombian President Ivan Duque, former US Ambassador to Brazil Liliana Ayalde, Argentine Economy Minister Martín Guzmán, Mexican Finance Minister Arturo Herrera Gutiérrez, and Brazil Central Bank President Roberto Campos Neto. See a complete list of speakers.

Intended for corporate decision makers and investors interested in Latin America, this extraordinary event brings together a range of leaders and Eurasia Group analysts to address a pandemic that has led to massive changes for public health, politics, and the economy.

Themes that will be addressed at the GZERO Summit Latin America include:

  • Post-pandemic politics
  • US-China tensions playing out in Latin America
  • The transition to a low-carbon environment
  • The role of the busines community in a post-pandemic world


About Eurasia Group:

Eurasia Group is the world’s leading global political risk research and consulting firm. By providing information and insight on how political developments move markets, we help clients anticipate and respond to instability and opportunities everywhere they invest or do business. Our expertise includes developed and developing countries in every region of the world, specific economic sectors, and the business and investment playing fields of the future. With our best-in-class advisory and consulting offerings and GZERO Media, the Eurasia Group umbrella provides the marketplace with a complete political risk solution. Headquartered in New York, we have offices in Washington DC, London, San Francisco, Brasilia, Sao Paulo, Singapore, and Tokyo, as well as on-the-ground experts and resources in more than a hundred countries. “Politics first” grounds our work: Politics is the lens through which we view the world, and we are committed to analysis that is free of political bias and the influence of private interests.

About B3:

B3 S.A. (B3SA3) is one of the main financial market infrastructure companies in the world and one of the largest in terms of market capitalization among global leaders in the exchange industry. B3 connects, develops, and enables the financial and capital market and, together with customers and society, boosts Brazil’s growth.

It trades in stock exchange and OTC environments, and offers products and services to the financing chain. Headquartered in São Paulo and with offices in London and Shanghai, B3 performs important functions in the market by promoting best practices in corporate governance, risk management and sustainability. B3. With the market. For the future.

Media Inquiries:

Gregory Roth

Director of Communications

Eurasia Group / GZERO Media

roth@eurasiagroup.net

Share article on social media or email:

AquiSense to Use NS Nanotech ShortWaveLight™ Emitters in New Research Products


The new AquiSense products will help accelerate the role of UVC and far-UVC light as potent weapons against coronavirus and future pathogens

AquiSense Technologies will integrate NS Nanotech’s solid-state emitters of UVC and far-UVC light into new products for researchers studying the disinfectant properties of light, the companies announced today. AquiSense, the global leader in UVC LED disinfection technology, said its products will be the first to offer academic, government, and private industry researchers access to a semiconductor far-UVC light source.

“The Covid-19 pandemic has created a growing need for better data on the safety and efficacy of UV-C technology,” said AquiSense CEO Oliver Lawal. “We are excited about the research possibilities of lower wavelength solid-state semiconductors integrated into our PearlLab™ product line which are expected to be ready for purchase in 2021.”

NS Nanotech’s ShortWaveLight™ Emitter, announced in November 2020, will be the world’s first solid-state solution to generate far-UVC light at wavelengths of 222 nanometers or less. Recent academic studies have indicated that far-UVC light effectively inactivates human coronaviruses (alpha HCoV-229E¹ and SARS-CoV-2²) and that its shorter wavelength is less harmful to human skin than longer-wavelength UVC light³. While this research is promising, more studies will help solidify these claims, aiding in the expansion and adoption of far UVC technology in the coming months and years.

Two New Research Tools

“We are delighted we can help AquiSense provide the best tools for researchers studying disinfection properties of UVC light, making far-UVC sources broadly available to the research community,” said NS Nanotech CEO Seth Coe-Sullivan. “The new AquiSense products will help accelerate the role of UVC and far-UVC light as potent weapons against coronavirus and future pathogens.”

NS Nanotech’s ShortWaveLight™ Emitters will be used in two new AquiSense research tools.

  • The PearlLab Beam 200-400™ will use the UVC ShortWaveLight™ Emitter, which generates light in the entire range of UV spectrum, from 200-to-400nm. This can be used to study the effects of broadband light as a germicide, or in combination with filter sets to select any UV wavelength of particular interest.
  • The PearlLab Beam 200-230™ will use the Far-UVC ShortWaveLight™ Emitter, which generates light in the narrower far-UVC spectrum range, from 200-to-230nm. This is a critical research tool in any study of the safety and efficacy of far-UVC light.

AquiSense research tools utilize solid-state solutions that are smaller and easier to use than devices that rely on an earlier generation of technology based on mercury lamps that are often expensive, cumbersome, difficult to operate, and potentially dangerous.

About NS Nanotech

NS Nanotech’s patented technologies, drawing on a decade of work on nitride semiconductors by researchers at McGill University and the University of Michigan, dramatically improve the fabrication process and resulting efficiency of nano-scale light-emitting materials. NS Nanotech ShortWaveLight™ Emitters are the first devices that utilize solid-state semiconductors to generate far-UVC light. And the portable, personal ShortWaveAir™ Purifier is a consumer product that emits far-UVC light to neutralize virus and bacteria in the user’s personal airspace.

About AquiSense

AquiSense Technologies is the global leader in UV-C LED systems design and manufacture. They work with leading LED manufacturers to evaluate their devices and then design efficient disinfection products. Using a combination of patented technology and in-depth know-how, AquiSense integrates LED devices into products that solve real world problems in water, air, and surface applications (http://www.aquisense.com).

¹Far-UVC efficacy study (SARS-CoV-2):

  • Effectiveness of 222-nm Ultraviolet Light on Disinfecting SARS-CoV-2 Surface Contamination, American Journal of Infection Control (AJIC), 2020.

²Far-UVC efficacy study (alpha HCoV-229E):

  • Far-UVC Light (222-nm) Efficiently and Safely Inactivates Airborne Human Coronaviruses, Nature, 2020.

³ Far-UVC human safety studies:

  • Repetitive Irradiation with 222-nm UVC Shown to be Non-Carcinogenic & Safe for Sterilizing Human Skin, Kobe University, 2020.
  • Germicidal Efficacy and Mammalian Skin Safety of 222-nm UV Light, Radiation Research, 2017.

Share article on social media or email:

Tipton Health Forges New Strategic Alliance with Nurse Builders


Tipton Health Communications is excited to announce its strategic alliance with Nurse Builders, a nursing education company that supports clinical practice excellence through certification review, continuing education and mentoring. This new alliance will provide Tipton clients with access to Nurse Builders’ comprehensive library of e-courses.

Through this strategic partnership, Tipton Health clients will receive a discount on Nurse Builders’ materials, including:

  • Certification review courses
  • Continuing education e-courses across specialties, including leadership

In collaboration with Nurse Builders, Tipton will begin offering continuing education certificates and contact hours for its Nursing Leadership Webinar Series beginning in 2021.

“We are strong advocates for continuing education and driving improvements in the nursing field,” said Dan Tipton, president and CEO of Tipton Health. “Nurse Builders’ comprehensive suite of continuing education resources will perfectly complement the services we have available to nurses, such as our Learning Needs Assessment tool and free nursing leadership webinars.”

Louise Jakubik, PhD, RN, NPD-BC, CSP, CEO/CLO of Nurse Builders shared: “Nurse Builders’ strategic alliance with Tipton Health is an outgrowth of our mutual commitment to facilitating nursing excellence through continuing education. We are thrilled to be providing both contact hours and e-courses to Tipton’s clients through this strategic alliance.”

For more information about the comprehensive, evidence-based resources available through this strategic partnership, please visit https://tiptonhealth.com/contact-us/.

About Tipton Health Communications

Tipton Health Communications is a leading provider of executive nurse consulting and mentoring; nursing excellence program development; and Magnet®, Pathway to Excellence® and Practice Transition Accreditation Program™ consulting support to the nation’s hospital and healthcare systems. In addition, Tipton Health supports clients nationwide with award-winning communications services, including employee communications, human resources communications, public relations, marketing communications, intranet and Internet design, graphic design, and strategic communications. For more information, please visit tiptonhealth.com.

Share article on social media or email:

Masson Spine Institute Park City Named as an Investigational Site for Centinel Spine’s SMART™ Clinical Study


Dr Robert Masson Spine Surgeon of Masson Spine Institute

We are pleased to announce that our outpatient surgery center at Masson Spine Institute Park City has been named as an investigational site for Centinel Spine’s SMART study, an FDA clinical trial for two level Prodisc C artificial disc.

THE SMART™ CLINICAL STUDY, sponsored by Centinel Spine will evaluate the safety and efficacy for two level Prodisc C in cervical disc injury. The primary purpose of the study is to show that the prodisc C SK and prodisc C Vivo are at least as safe and effective as a similar, currently marketed cervical disc prosthesis (Mobi-C) to treat symptomatic cervical disc disease (SCDD) in patients at two contiguous levels from C3 to C7.

“This is big news for the Masson Spine Institute Park City, and we are proud to bring the first of many national spine surgical investigational studies to the community of Park City.” – Dr. Robert L. Masson, Spine Surgeon and Founder of the Masson Spine Institute.

MSI Park City is currently enrolling patients interested in a two-level arthroplasty solution who are willing to be included in a landmark investigational trial in the United States.

Visit the SMART™ Clinical Study information page to learn more about the study and patient eligibility.

About Masson Spine Institute

The Masson Spine Institute is a passionate advocate for prevention, wellness, fitness, and ultimately extreme recovery in the face of spinal injury and encourages patients to become experts in their injury and to continue to ask questions about their injury and their treatment until the strategy makes sense to them. MSI patients are the most prepared for the pathway of recovery because they understand the sacrifices and commitment that they need to make in order to succeed and to become healthy and functionally active.

About Centinel Spine

Centinel Spine, LLC is a privately-held spinal device company leading the development and commercialization of the Stand-Alone, No-Profile, Integrated Interbody fusion technologies. The company began operations in August 2008, through the merger-acquisition of two pioneering medical device companies: Raymedica LLC and Surgicraft LTD. Today, Centinel Spine still embraces the pioneering culture developed at both originating companies and continues its corporate mission of becoming the leading anterior column support spine franchise, providing elegantly simple implants and instruments that are tissue-sparing and generating superior clinical outcomes.

Media Contact:

Stephanie Florez

stephanie@massonsi.com

Ph: 407-649-8585 ext 244

Fax: 407-347-9523

Share article on social media or email:

Promises Behavioral Health Welcomes Sam Macmaster, PhD. as Corporate Director of Clinical Operations


Promises Behavioral Health Announces Sam MacMaster, Ph.D. as Corporate Director of Clinical Operations

I want to help create sound, research-based care that supports clients and their families to better understand and work through the depths of their chronic mental health and substance use disorders.

Promises Behavioral Health, a leader in addiction and mental health treatment services, announced today the addition of its new Corporate Director of Clinical Operations. Sam MacMaster joins the Promises corporate team as a leader in mental health and substance use disorder program design and service delivery. With over 30 years of experience, Sam brings his wealth of knowledge to the team as Promises gears up for a year of growth.

Sam began his behavioral health career shortly after his own recovery in 1988, working in a variety of addiction treatment centers for over a decade. During this time, Sam pursued his academic goals, earning a bachelor’s in psychology from Miami University, his master’s of science in social administration at Case Western Reserve University and finally getting his Ph.D. as a doctor in social welfare. Dr. MacMaster was a tenured member of the faculty at the College of Social Work at the University of Tennessee in Nashville while also conducting important research on addiction and access to care. He would later move on to Baylor College of Medicine in Houston, Texas, where he continues to be engaged in research on behavioral health as a member of the faculty in the Department of Family and Community Medicine. During this time, Sam also co-founded Journey Pure, which focused on providing accessible and affordable addiction care.

As the Corporate Director of Clinical Operations, Sam will help design, deliver and ensure that the treatment services are of the highest quality of care and backed by conclusive research and clinical evidence. Sam is driven to truly help people find themselves through scientifically effective addiction and mental health treatment services. With his extensive experience in behavioral health programming planning, he understands what it takes to provide quality treatment that is affordable and accessible to make a meaningful impact on clients.

“I am excited to be a part of the Promises Behavioral Health team,” said Sam MacMaster. “I want to help create sound, research-based care that supports clients and their families to better understand and work through the depths of their chronic mental health and substance use disorders.”

As Sam steps into this role, Promises can expect a passionate leader who will uphold the vision of inspiring communities to accept and empower individuals through healing. Guided by this vision, Sam and all of the Promises Behavioral Health team and their family of treatment centers can expect thoughtful growth in the coming year.

About Promises Behavioral Health

Promises Behavioral Health is a family of behavioral health programs with regional brands such as The Right Step, The Ranch and Promises. The company currently operates facilities across Texas, Tennessee, Florida, Pennsylvania and Massachusetts. Promises offers comprehensive, innovative treatment for substance abuse, sexual addiction, trauma, eating disorders and other mental health disorders. Through its programs, the company is committed to delivering clinically sophisticated treatment that promotes permanent lifestyle change, not only for the patient but for the entire family network. For more information, please visit http://www.PromisesBehavioralHealth.com.

Share article on social media or email: